Company / Current Liabilities
Monopar Therapeutics Current Liabilities History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.7M
FY2025
5-year range
$399.6K / $2.7M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities changed +278% YoY in FY2025, a notable deviation from the 3-year average annual change of +129%.
Based on SEC 10-K filings.
$3M in FY2025.
Increased from $399,551 to $3M over the past 7 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 19.82 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2019 | $724.2K | +81.2% |
| FY2018 | $399.6K | +28.1% |
| FY2017 | $311.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026